Почетна › Hronična limfocitna leukemija › Северна Каролина › Durham
Kliničke studije za Hronična limfocitna leukemija u gradu Durham, NC
28 studija za Hronična limfocitna leukemija traži učesnike na lokacijama u gradu Durham i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 ми удаљено
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Тражи се учесникФаза 3
- Duke Adult Blood and Marrow Clinic, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Durham VA Medical Center, Durham
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Тражи се учесникФаза 2
- Duke University, Durham
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Тражи се учесникФаза 2
- Durham VA Medical Center, Durham, NC, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Тражи се учесникОпсервациона студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ми удаљено
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Тражи се учесникФаза 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 ми удаљено
MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab
Тражи се учесникФаза 2
- Research Site, Durham
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Тражи се учесникФаза 3
- University of North Carolina At Chapel Hill, Chapel Hill · 10 ми удаљено
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Тражи се учесникФаза 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Тражи се учесникФаза 3
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Тражи се учесникФаза 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 ми удаљено
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Тражи се учесникФаза 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 ми удаљено
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Тражи се учесникФаза 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Тражи се учесникФаза 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Тражи се учесник
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 ми удаљено
Registry of Older Patients With Cancer
Тражи се учесникОпсервациона студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ми удаљено
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Тражи се учесникФаза 1
- University of North Carolina, Chapel Hill · 10 ми удаљено
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Тражи се учесникФаза 4
- Duke University Medical Center, Durham
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Тражи се учесникФаза 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Тражи се учесникФаза 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Тражи се учесникФаза 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 ми удаљено
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Тражи се учесникФаза 1
- Duke University, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Тражи се учесникФаза 1
- University of North Carolina, Chapel Hill · 10 ми удаљено
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Тражи се учесникФаза 1
- Duke University, Durham
Studije za Hronična limfocitna leukemija u drugim gradovima
- Boston, MA31 студија
- Columbus, OH29 студија
- Washington, DC22 студија
- Seattle, WA22 студија
- Rochester, MN20 студија
- New York City, NY20 студија
- Houston, TX18 студија
- Baldwin Park, CA18 студија
- Cincinnati, OH15 студија
- Milwaukee, WI15 студија
- Chicago, IL14 студија
- Nashville, TN13 студија
Ostale studije u gradu Durham
- Рак дојке63 студија
- Рак (све врсте)61 студија
- Немалоклетни карцином плућа42 студија
- Многи мијелом36 студија
- Akutna mijeloidna leukemija34 студија
- Рак плућа33 студија
- Метастатски карцином33 студија
- Рак простате32 студија
- Колоректални карцином30 студија
- Рак јајника28 студија
- Затајење срца25 студија
- Рак панкреаса24 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.